Nesina

(Alogliptin)

Nesina

Drug updated on 11/13/2023

Dosage FormTablet (oral; 6.25 mg, 12.5 mg, 25 mg)
Drug ClassDipeptidyl peptidase-4 inhibitors
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.